See also this year's filing and all EDGAR filings for this company.
PDF Report 0001044378_2022_Biocept_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001044378')"} |
Graph
Absolute values for 0001044378, Biocept INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 9,482,000 |
| 2 | AssetsCurrent | 45,692,000 |
| 3 | PropertyPlantAndEquipment | 2,401,000 |
| 4 | remainder_Assets | 2,842,000 |
| 5 | LongTermLiabilities | 9,736,000 |
| 6 | LiabilitiesCurrent | 11,773,000 |
| 7 | remainder_Liabilities | 1,428,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 37,764,000 |
| 10 | GeneralAndAdministrativeExpense | 12,614,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 8,320,000 |
| 15 | ResearchAndDevelopmentExpense | 4,960,000 |
| 16 | remainder_Expenses | 125,000 |
| 17 | remainder_Revenues | 61,249,000 |
| 18 | remainder_NetIncome | -290,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 60,417,000 |
| 1 | Liabilities | 22,937,000 |
| 2 | Expenses | 63,783,000 |
| 3 | Revenues | 61,249,000 |
| 4 | StockholdersEquity | 37,480,000 |
| 5 | NetIncome | -2,824,000 |
| 6 | ComprehensiveNetIncome | -2,824,000 |
| 7 | BaseVar | 104,338,000 |
| 8 | EconomicCapitalRatio | 2.43 |
Edgar->Model Mapping
Feature Distribution
Change over Time
